Recruiting
Phase 1

B-Cell Targeted Carfilzomib Desensitization

Sponsor:

E. Steve Woodle

Code:

NCT02442648

Conditions

Transplants and Implants

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Carfilzomib

Rituximab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information